Fifty-two-week, randomized, multicenter trial to compare...

Fifty-two-week, randomized, multicenter trial to compare the safety and efficacy of the novel glucagon-like peptide-1 analog liraglutide vs glibenclamide in patients with type 2 diabetes

Kohei Kaku, Mads Frederik Rasmussen, Tomoyuki Nishida, Yutaka Seino
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
2
Year:
2011
Language:
english
DOI:
10.1111/j.2040-1124.2011.00128.x
File:
PDF, 189 KB
english, 2011
Conversion to is in progress
Conversion to is failed